Northwire Canada EditionFriday, October 16, 2026
Northwire
⌕
GOLD 4170.10 +1.5% SILVER 57.16 +2.3% COPPER 6.56 −1.5% OIL 97.97 +3.0% PALLADIUM 1136.00 +3.6% LUN 32.91 +0.6% DLP 0.290 −3.3% VCV 0.065 −13.3% GG 2.89 +1.4% NBLC 0.015 +0.0% SF 0.300 −4.8% ATY 0.215 +2.4% GHL 0.060 −7.7% STND 0.060 −7.7% B 0.550 −3.5% HBM 34.33 −0.5% NTR 98.77 −0.7% SGZ 0.035 +0.0% MKA 0.670 +0.0% LXM 0.175 −18.6% CLCH 1.08 −1.8% GOLD 4170.10 +1.5% SILVER 57.16 +2.3% COPPER 6.56 −1.5% OIL 97.97 +3.0% PALLADIUM 1136.00 +3.6% LUN 32.91 +0.6% DLP 0.290 −3.3% VCV 0.065 −13.3% GG 2.89 +1.4% NBLC 0.015 +0.0% SF 0.300 −4.8% ATY 0.215 +2.4% GHL 0.060 −7.7% STND 0.060 −7.7% B 0.550 −3.5% HBM 34.33 −0.5% NTR 98.77 −0.7% SGZ 0.035 +0.0% MKA 0.670 +0.0% LXM 0.175 −18.6% CLCH 1.08 −1.8%
M&A / Property

The Cannabist Company Announces Agreement for the Sale of Virginia Assets to an Affiliate of Millstreet following Go-Shop

CBST · Price

Executive Summary

  • The Cannabist Company entered into an Equity Purchase Agreement to sell its Virginia subsidiary, Green Leaf Medical of Virginia, LLC, for a total consideration of $130 million.
  • The transaction includes $117.5 million cash at closing and a $12.5 million escrow amount, with $23.7 million deposited immediately after signing.
  • The company will use a portion of the net proceeds to redeem its senior secured notes.

Key Details

  • Transaction Parties: Seller – Green Leaf Medical of Virginia, LLC (subsidiary of The Cannabist Company) and its member Green Leaf Medical, LLC; Buyer – Parma Holdco LLC, with Millstreet Credit Fund LP as limited purpose affiliate.
  • Consideration: $130 million total; $117.5 million payable in cash at closing; $12.5 million placed in escrow (up to $1 million released after post‑closing purchase price adjustment, remainder held for up to nine months).
  • Escrow Deposit: Buyer will deposit $23.7 million within two business days of signing; release conditions: (i) to the Company at closing or upon termination due to material breach, or (ii) to Buyer otherwise.
  • Closing Timeline: Expected early 2026 or sooner, subject to regulatory approvals and satisfaction/waiver of customary closing conditions.
  • Use of Proceeds: Portion earmarked for redemption of the company’s 9.25% Senior Secured Notes due Dec 31 2028 and 9.0% Senior Secured Convertible Notes due Dec 31 2028.
  • Termination of Curaleaf Agreement: On Dec 18 2025, The Cannabist Company terminated its prior Equity Purchase Agreement with Curaleaf, paying a $3.3 million break‑up fee.
  • Asset Description: 5 active retail locations in Virginia, 1 additional location under development, and ~82,000 sq ft of cultivation/production capacity in the Richmond region.
  • Advisors: Moelis & Company (financial advisor); Stikeman Elliott LLP (Canadian counsel); Weil, Gotshal & Manges LLP and Foley Hoag LLP (U.S. counsel).

Notable Quotes

(No direct quotes were provided in the release.)

Read the original news release →

More from THE CANNABIST COMPANY HOLDINGS INC.